The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed
prospectively is compared to that reported in the literature. Asymptomatic elevation of serum …

Potential hepatotoxicity related to amiodarone therapy is often a concern when deciding
whether to initiate or continue treatment with this medication. While mostly associated with …

This analysis of the morphology of suspected amiodarone (AD) liver disease is based on a
study of liver specimens from 17 individuals. Changes similar to alcoholic liver injury were …

Five patients had amiodarone hepatotoxicity detected on routine biochemical monitoring.
Symptoms attributable to hepatotoxicity were minimal or absent; reversible hepatomegaly …

Cholestasis has been reported as a rare presentation among patients with severe liver injury
secondary to amiodarone hepatic toxicity. We report an unusual case of amiodarone …

AMIODARONE, an iodine-containing benzofuran derivative, has been widely available in
Europe for over 15 years, but its use in North America is still experimental. The drug has …

The aim of this work was to compare hepatocellular toxicity and pharmacological activity of
amiodarone (2-n-butyl-3-[3, 5 diiodo-4-diethylaminoethoxybenzoyl]-benzofuran; B2-O-Et-N …

A 72 year old white man developed acute hepatic impairment and renal failure within 24
hours of starting intravenous amiodarone for paroxysmal ventricular tachycardia. After …

Amiodarone is an amphiphilic iodinated compound that is used as a treatment for refractory
ventricular arrhythmias. During evaluation for possible pulmonary toxicity, a patient receiving …

In order to study the relationship between amiodarone‐induced hepatic phospholipidosis
and liver disease, liver biopsies obtained from 13 patients treated with amiodarone for 4 …